Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (283)
- COVID-19 (163)
- Safety monitoring and information (108)
- Compliance and enforcement (79)
- Legislation (77)
- Manufacturing (58)
- Vaping hub (56)
- Labelling and packaging (38)
- Import and export (33)
- Scheduling (national classification system) (27)
- Medicinal cannabis hub (25)
- Sunscreens (20)
- Weight loss products (15)
- Shortages and supply disruptions (13)
- Committees and advisory bodies (9)
- Cosmetics (5)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1262 result(s) found, displaying 826 to 850
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines
-
News articlesThe granting of this determination means that Pfizer is now eligible to apply to vary its provisional registration for the vaccine for use in individuals 12 years of age or older.
-
Media releasesThe infringement notice relate to the alleged failure to provide information on a contact person responsible for medicine safety.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines
-
News articlesThe TGA is warning consumers about the risks of buying medicinal cannabis products online
-
News articlesThe TGA is reminding businesses involved with medicinal cannabis products of their regulatory obligations under the Therapeutic Goods Act 1989
-
Safety updatesMedicines Safety Update article
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines
-
Media releasesGlobal Therapeutics Pty Ltd has paid penalties of $119,880 in response to nine infringement notices
-
News articlesThe TGA have made some changes to the SAS & AP Authorised Prescriber Online System.
-
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines
-
News articlesThe granting of a provisional determination means that the TGA has made a decision that GSK is now eligible to apply for provisional registration for the treatment in the Australian Register of Therapeutic Goods.
-
Media releasesUpdated safety advisory - rare and unusual blood clotting syndrome (thrombosis with thrombocytopenia)
-
Media releasesTGA has recently approved wider storage and transportation conditions for the Pfizer COVID-19 vaccine in Australia
-
News articlesUpdated storage conditions for the Pfizer COVID-19 vaccine
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines
-
Media releasesThe TGA is investigating the advertising of stem cell therapies to ensure that content in the public domain complies with the Australian rules for advertising therapeutic goods.
-
News articlesThe Scheduling Delegate has decided to seek further advice in relation to psilocybin and MDMA
-
Media releasesSome rare cases of thrombosis associated with thrombocytopenia have been reported overseas following the administration of COVID-19 Vaccine AstraZeneca.
-
Media releasesAustralia’s vaccine safety and regulatory process is world class and people can be confident that vaccines approved for use are safe and effective.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines
-
Regulatory decision noticesNew legislative instrument
-
News articlesSunscreen SPF testing by AMA Laboratories - Regulatory update. Possible fraudulent testing of sunscreens and TGA efforts to mitigate effect on Australian consumers.